Filing Details

Accession Number:
0001225208-12-019611
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-14 10:41:07
Reporting Period:
2012-09-11
Filing Date:
2012-09-14
Accepted Time:
2012-09-14 10:41:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278271 Jerome Mark Pykett 425 Metro Place North
Suite 450
Dublin OH 43017
Pres. & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-09-11 4,000 $2.64 307,300 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,198 Indirect By 401(k)
Common Stock 1,100 Indirect By IRA